If I recall correctly, stock spiked into 1st interim analysis which did not result in stop...then sold off. Then up again as partnerships and Ebola took headlines. Looks like the opposite as we approach end of IMPRESS. Who knows. Last time I recall it was around $17 felt a lot like today, then next thing it was up up and away to $50. Tough to ride up and down multiple times for huge gains & losses, but I like this company. I believe they outwork the competition and will eventually be winners.
Pleeeeze. Planned sales are planned sales. If they occur during a fda review, favorable or not, is immaterial - Too many conspiracy theories dude. Who complains if the trial succeeds and link sold all those shares you elude to?
Looks like NLNK made this list today on nasdaq site - not exactly sure what the list does to a stocks trading pattern...
Short Sale Circuit Breaker
The SEC adopted amendments to Regulation SHO with a compliance date of November 10, 2010. Among the rule changes, the SEC introduced Rule 201 (Alternative Uptick Rule), a short sale-related circuit breaker that when triggered, will impose a restriction on prices at which securities may be sold short. The SEC also issued guidance for broker-dealers wishing to mark certain qualifying orders 201cshort exempt.201d For more details, refer to Amendments to Regulation SHO (Release 34-61595).